Search results
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 1 day agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell? | The Motley Fool
The Motley Fool· 6 days agoNovavax (NVAX -4.30%) took a turn in the investor spotlight in early May, when the vaccine...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 5 days agoIn the past six months, shares of MRNA have rallied 69.04%. (See the last biotech stock roundup...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 2 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
Motley Fool via Yahoo Finance· 5 days agoAnd here's even better news: The Sanofi agreement could be a game changer for Novavax, so there's...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 5 days agoTogether with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
The Motley Fool via AOL· 5 days agoAnd here's even better news: The Sanofi agreement could be a game changer for Novavax, so there's...
Exploring Euronext Paris Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 13 hours agoAmidst a backdrop of cautious optimism in European markets, where the CAC 40 Index recently saw a modest decline, investors continue to seek stable...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 1 day agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 4 days agoIn contrast, Moderna has more than 40 candidates in the pipeline, and as mentioned above, expects to launch several products within the next few years....